129 related articles for article (PubMed ID: 8177707)
1. [Z-100 as radiation mucositis protector in head and neck tumor management].
Miyashita T; Morita S; Shibuya H; Takeda M; Horiuchi J
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):295-7. PubMed ID: 8177707
[TBL] [Abstract][Full Text] [Related]
2. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
3. [Immunoglobulin for prevention of radiogenic mucositis].
Mose S; Adamietz IA; Thilmann C; Saran F; Heyd R; Knecht R; Böttcher HD
HNO; 1995 Jul; 43(7):421-6. PubMed ID: 7672999
[TBL] [Abstract][Full Text] [Related]
4. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
5. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
Su CK; Mehta V; Ravikumar L; Shah R; Pinto H; Halpern J; Koong A; Goffinet D; Le QT
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):171-7. PubMed ID: 15337553
[TBL] [Abstract][Full Text] [Related]
6. [Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors].
Altmann S; Hoffmanns H
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():30-3. PubMed ID: 10584138
[TBL] [Abstract][Full Text] [Related]
7. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
[TBL] [Abstract][Full Text] [Related]
9. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study.
Buentzel J; Micke O; Adamietz IA; Monnier A; Glatzel M; de Vries A
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):684-91. PubMed ID: 16243440
[TBL] [Abstract][Full Text] [Related]
10. [The problem of radiogenic and chemotherapy-induced mucositis of the mouth and and oropharynx exemplified by accelerated radiochemotherapy with carboplatin in patients with inoperable squamous epithelial carcinomas of the head-/neck area. Heidelberg experiences].
Dietz A; Nollert J; Maier H; Rudat V; Flentje M
HNO; 1995 Jul; 43(7):403-13. PubMed ID: 7545657
[TBL] [Abstract][Full Text] [Related]
11. [Clinical effects of adjuvant therapy using Z-100 (Ancer 20 injection) for oral cancer--prevention of stomatitis and hematopoietic impairment].
Okutomi T; Kato Y; Ichihara H; Hyodo I; Fujitsuka H; Yasuda S; Tatematsu N
Gan To Kagaku Ryoho; 2000 Jan; 27(1):65-71. PubMed ID: 10660735
[TBL] [Abstract][Full Text] [Related]
12. [Cytoprotection with amifostine in the framework of radiochemotherapy in previously irradiated head and neck carcinoma].
Büntzel J; Glatzel M; Schuth J; Weinaug R; Küttner K; Fröhlich D
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():37-40. PubMed ID: 10584140
[TBL] [Abstract][Full Text] [Related]
13. [Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial].
Vacha P; Marx M; Engel A; Richter E; Feyerabend T
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():18-22. PubMed ID: 10584135
[TBL] [Abstract][Full Text] [Related]
14. Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy.
Murphy BA; Beaumont JL; Isitt J; Garden AS; Gwede CK; Trotti AM; Meredith RF; Epstein JB; Le QT; Brizel DM; Bellm LA; Wells N; Cella D
J Pain Symptom Manage; 2009 Oct; 38(4):522-32. PubMed ID: 19608377
[TBL] [Abstract][Full Text] [Related]
15. Reduced incidence and severity of acute radiation mucositis by WF10 (IMMUNOKINE) as adjunct to standard of cure in the management of head & neck cancer patients.
Penpattanagul S
J Med Assoc Thai; 2007 Aug; 90(8):1590-600. PubMed ID: 17926989
[TBL] [Abstract][Full Text] [Related]
16. [Can the prophylactic treatment of mycotic mucositis improve the time of performing radiotherapy in head and neck tumors?].
Gava A; Ferrarese F; Tonetto V; Coghetto F; Marazzato G; Zorat PL
Radiol Med; 1996 Apr; 91(4):452-5. PubMed ID: 8643858
[TBL] [Abstract][Full Text] [Related]
17. Mucositis: current management and investigations.
Garden AS
Semin Radiat Oncol; 2003 Jul; 13(3):267-73. PubMed ID: 12903015
[TBL] [Abstract][Full Text] [Related]
18. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients.
Rades D; Fehlauer F; Bajrovic A; Mahlmann B; Richter E; Alberti W
Radiother Oncol; 2004 Mar; 70(3):261-4. PubMed ID: 15064010
[TBL] [Abstract][Full Text] [Related]
19. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3).
Bjarnason GA; Mackenzie RG; Nabid A; Hodson ID; El-Sayed S; Grimard L; Brundage M; Wright J; Hay J; Ganguly P; Leong C; Wilson J; Jordan RC; Walker M; Tu D; Parulekar W;
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):166-72. PubMed ID: 18805649
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy of head-neck neoplasms: prevention of inflammation of the mucosa by sucralfate treatment].
Scherlacher A; Beaufort-Spontin F
HNO; 1990 Jan; 38(1):24-8. PubMed ID: 2179176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]